Atrial Fibrillation, Device Related Thrombosis, Stroke, Ischemic
Conditions
Keywords
Left Atrial Appendage Occlusion, Cardiac Computed Tomography, Watchman FLX
Brief summary
The APPEND-CT registry is an investigator-driven multicenter retrospective observational database intended to compile cardiac CT follow-up data after Watchman FLX device implantation and function as a platform for answering clinical and research questions within LAAC follow-up. The derived studies should support therapeutic decision-making, improve risk-stratification in LAAC and help generate hypotheses for potential future clinical intervention trials.
Detailed description
An investigator-driven multicenter retrospective observational database enrolling patients from high-volume North American and European centers. The database will include Watchman FLX implanted patients with a minimum of one follow-up cardiac CT performed within 45-120 days post-procedure. Additional timepoints may be entered. Cardiac CT scans are to be uploaded and will be analyzed by the core-lab at Aarhus University Hospital. Investigator-reported findings will be systematically reported to the database. This includes information on baseline characteristics, preprocedural planning, implantation details, discharge medication, follow-up imaging and clinical endpoints of interest. As a minimum, investigator-reported endpoints will be collected from patient registries at one-year follow-up by site-investigators. Endpoints of interest include ischemic stroke, systemic embolism, major bleeding, mortality, device-related thrombosis, pericardial effusion, vascular complications, and device migration.
Interventions
Early (30-120 days) CT follow-up after Watchman FLX LAAO
Sponsors
Study design
Eligibility
Inclusion criteria
* Watchman FLX LAAO * A minimum of one follow-up cardiac CT performed within 30-120 days post-procedure. * A minimum of one year clinical follow-up data
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Ischemic stroke | Minimum 12 months | Clinically affirmed ischemic stroke |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Device-related thrombosis | Minimum 12 months | High-grade hypoattenuated thickening as seen on cardiac CT |
| Major bleeding | Minimum 12 months | BARC \>=2 |
| All-cause and cardiovascular mortality | Minimum 12 months | As defined in the Munich consensus |
Countries
Denmark, United States